Close

Chardan Capital Markets Reiterates Buy Rating on Immatics (IMTX) on BMY Deal

December 14, 2021 12:18 PM EST Send to a Friend
Chardan Capital Markets analyst Geulah Livshits reiterated a Buy rating and $30.00 price target on Immatics (NASDAQ: IMTX) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login